Serum matrix metalloproteinase-3 in hemodialysis patients with dialysis-related amyloidosis

Hemodialysis International

Volumn 8, Issue 3, 2004, Pages 219-225

  Ishizaki, Makoto ^a,b   Matsunaga, Tomohito ^a   Adachi, Kuniaki ^a   Miyashita, Eishi ^a  

^a Kidney Center   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; C REACTIVE PROTEIN; INTERLEUKIN 6; STROMELYSIN;

ADULT; AMYLOIDOSIS; ARTHRITIS; ARTICLE; ARTIFICIAL KIDNEY; BONE CYST; BONE EROSION; CARPAL TUNNEL SYNDROME; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DILUTION; ENZYME BLOOD LEVEL; FEMALE; FEVER; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; LONG TERM CARE; MALE; PROGNOSIS; STATISTICAL SIGNIFICANCE;

EID: 22644435939     PISSN: 14927535     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1492-7535.2004.01099.x     Document Type: Article

References (15)

1. Gejyo F, Yamada T, Odani S, Nakagawa Y, Arakawa M, Kunitomo T, Kataoka H, Suzuki M, Hirasawa Y, Shirahama T, Cohen AS, Schmid K. A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin. Biochem Biophys Res Commun. 1985; 129(3):701-706.
2. 2-microglobulin-associated amyloid. Nephrol Dial Transplant. 1998; 13(6):1465-1475.
3. Ohashi K. Pathogenesis of beta2-microglobulin amyloidosis. Pathol Int. 2001; 51(1):1-10.
4. Ito A, Itoh Y, Sasaguri Y, Norimatsu M, Mori Y. Effects of interleukin-6 on the metabolism of connective tissue components in rheumatoid synovial fibroblasts. Arthritis Rheum. 1992; 35(10):1197-1201.
5. Sasaki S, Iwata H, Ishiguro N, Obata K, Miura T. Detection of stromelysin in synovial fluid and serum from patients with rheumatoid arthritis and osteoarthritis. Clin Rheum. 1994; 13(2):228-233.
6. Yoshihara Y, Obata K, Fujimoto N, Yamashita K, Hayakawa T, Shimmei M. Increased levels of stromelysin-1 and tissue inhibitor of metalloproteinases-1 in sera from patients with rheumatoid arthritis. Arthritis Rheum. 1995; 38(7):969-975.
7. Ishizaki M, Oikawa K, Miyashita E. Usefulness of the endotoxin test for assessing CAPD peritonitis by gram-negative organisms. Adv Perit Dial. 1996; 12:199-202.
8. Kaizu Y, Kimura M, Yoneyama T, Miyaji K, Hibi I, Kumagai H. Interleukin-6 may mediate malnutrition in chronic hemodialysis patients. Am J Kidney Dis. 1998; 31(1):93-100.
9. Pecoits-Filho R, Bárány P, Lindholm B, Heimbürger O, Stenvinkel P. Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant. 2002; 17(9):1684-1688.
10. Man NK, Ciancioni C, Faivre JM, Diab N, London G, Maret J, Wambergue FP. Dialysis-associated adverse reactions with high-flux membranes and microbial contamination of liquid bicarbonate concentrate. Contrib Nephrol. 1988; 62:24-34.
11. Herbelin A, Ureña P, Nguyen AT, Zingraff J, Descamps-Latscha B. Elevated circulating levels of interleukin-6 in patients with chronic renal failure. Kidney Int. 1991; 39(5):954-960.
12. Pertosa G, Gesualdo L, Tarantino EA, Ranieri E, Bottalico D, Schena FP. Influence of hemodialysis on interleukin-6 production and gene expression by peripheral blood mononuclear cells. Kidney Int Suppl. 1993; 39:S149-S153.
13. Caglar K, Peng Y, Pupim LB, Flakoll PJ, Levenhagen D, Hakim RM, Ikizler TA. Inflammatory signals associated with hemodialysis. Kidney Int. 2002; 62(4): 1408-1416.
14. Panichi V, Migliori M, De Pietro S, Metelli MR, Taccola D, Perez R, Palla R, Rindi P, Cristofani R, Tetta C. Plasma C-reactive protein in hemodialysis patients: A cross-sectional, longitudinal clinical survey. Blood Purif. 2000; 18(1):30-36.
15. Panichi V, Tetta C, Rind P, Palla R, Lonnemann G. Plasma C-reactive protein is linked to backfiltration associated interleukin-6 production. ASAIO J. 1998; 44(5):M415-M417.